News | October 19, 2009

ASTRO, Gilda's Club Partner to Raise Cancer Survivorship Awareness

October 19, 2009 - The American Society for Radiation Oncology (ASTRO) is partnering with Gilda's Club Chicago to raise awareness of cancer survivorship issues, as part of an initiative to give back to the communities in the cities visited during its annual scientific meetings.

Gilda's Club Chicago will work with ASTRO by participating in the Survivor Circle exhibit at ASTRO's 51st Annual Meeting, scheduled for November 1-5, 2009, at McCormick Place West in Chicago, Ill. The Survivor Circle was created to recognize those living with a diagnosis of cancer. This year, it will focus on the programs offered by Chicago-area cancer organizations helping patients and their families cope with this disease. Within the Survivor Circle, there is a place for attendees to learn more about this Gilda's Club. Gilda's Club received this opportunity, along with a $10,000 grant, through the Survivor Circle Grant Program. They were one of two groups chosen from 10 applications received this year.

"We are excited to work with such a well-established, nationally recognized organization," Tim R. Williams, president of ASTRO said. "Our patients and their families rely on the programs offered by groups like Gilda's Club Chicago and their programs are fully deserving of this grant and the opportunity to educate our members about the work they do to assist those living with cancer."

"We are honored to be selected by ASTRO to receive this grant and to be showcased at their exciting 51st Annual Meeting," LauraJane Hyde, CEO of Gilda's Club Chicago noted. "To be able to connect their global leadership with the work we are doing in Chicago to build welcoming communities for those affected by cancer is a great partnership."

For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...